JANN AMERY ABRENICA: Open Payments
NPI 1194381962 · CLIFTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$957 in 31 payments from 10 companies in 2025. Trend: 2023 $618 · 2024 $352 · 2025 $957
Food & beverage: $582Consulting: $375
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC | 2 | $429 |
| PFIZER INC. | 8 | $149 |
| Sumitomo Pharma America, Inc. | 7 | $119 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $87 |
| Janssen Biotech, Inc. | 4 | $51 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $24 |
| Teleflex LLC | 1 | $22 |
| Profound Medical Corp. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $19 |
Products named: ERLEADA, XTANDI, GEMTESA, Nubeqa, LYNPARZA, ORGOVYX, PYLARIFY, UROLIFT.
Industry payments across NJ — which companies pay providers there.
